Medable is taking its digital clinical trial platform to new heights: the Google Cloud Marketplace. Through the collaboration, Google Cloud’s infrastructure and AI features will be integrated into ...
Clinical trial software company Florence Healthcare announced Wednesday it had scored $27 million in a Series C-1 round led by Insight Partners. The startup said the investment brings its total raise ...
Choosing the right EDC (electronic data capture) platform is critical for sponsors, CROs, and clinical operations teams ...
If technology companies want to make a positive impact on healthcare, they need to explore ways to make clinical trials more accessible and efficient. Faster, more inclusive clinical trials lead to ...
Clinical trials technology company Science 37 went public during the Covid-19 pandemic, a time when drug developers readily embraced technologies that enable patients to participate in drug studies ...
eWEEK content and product recommendations are editorially independent. We may make money when you click on links to our partners. Learn More. Phase Forward, a startup provider of data management ...
More than 1,300 oncology drugs are in the development pipeline, waiting to potentially embark on the long journey toward their commercial debut. This journey is usually an arduous one, made even more ...
The clinical research industry embraced technology at a surprising rate in 2021. According to WCG Avoca, 97% of clinical trial sites used at least one form of remote tech by June 2021. Eighty-nine ...
The pandemic significantly changed how we do medical research, and now companies are trying to figure out what trends will stay and which ones will go. One that 4G Clinical is hoping will survive the ...
McGill University researchers have developed and are licensing a digital tool to help safely reduce patients' use of medications that may be unnecessary or even harmful to them. "Sometimes we blame ...
In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...
The calls to increase inclusion of underrepresented groups in clinical trials have been around for a while. Diversity is not a new subject in the drug development world, but biopharmas have struggled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results